Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The clinical nutrition market was valued at USD 53.75 Billion in 2025. It is poised to grow at a CAGR of 8.00% during the forecast period of 2026-2035, and reach USD 116.04 Billion by 2035. The market growth is driven by the increasing incidence of chronic diseases and disease-related malnutrition, along with the growing aging population and demand for specialized nutritional support.
According to ASPEN, the American Society for Parenteral and Enteral Nutrition hosted a webinar on April 22, 2026, to review its newly published evidence-based guidelines for nutrition in adults with head and neck cancer. The comprehensive guidelines address key clinical questions around enteral feeding, protein intake, and immunonutrition during cancer treatment, and are expected to standardize clinical nutrition practices and support further adoption of specialized enteral formulas across oncology care settings.
As published in the Journal of Parenteral and Enteral Nutrition, ASPEN released its landmark guidelines for nutrition management in adult head and neck cancer patients on March 3, 2026. The document provides causal-inference-based recommendations on enteral feeding initiation and protein supplementation, addressing critical gaps in clinical nutrition standards and driving demand for condition-specific nutritional formulations across hospitals and oncology centers.
In March 2026, Danone agreed to acquire plant-based nutrition company Huel for approximately USD 1.15 billion, strengthening its position in the clinical and functional nutrition segment.
In January 2026, the U.S. FDA announced priority deliverables under its Human Foods Program, focusing on improving nutrition standards to reduce chronic disease burden.
In September 2025, the National Home Infusion Association highlighted that over 220,000 U.S. patients rely on home enteral nutrition, emphasizing reimbursement and access challenges.
Compound Annual Growth Rate
8%
Value in USD Billion
2026-2035
The market is witnessing steady growth, driven by rising prevalence of chronic diseases, aging populations, and increasing awareness of disease-related malnutrition. Demand for specialized nutritional products, including enteral and parenteral formulations, is expanding across hospitals and home care settings. Technological advancements, improved formulations, and supportive healthcare policies are further contributing to market expansion globally. The market reached a value of approximately USD 53.75 Billion in 2025.
Increasing Adoption of Medical Nutrition in Disease Management to Boost the Market Expansion
The market is driven by rising chronic disease burden and increasing focus on therapeutic dietary interventions. For instance, in March 2026, Danone agreed to acquire Huel for USD 1.15 billion, strengthening its nutrition portfolio. This acquisition highlights growing industry investment in specialized nutritional solutions, supporting patient management, improving outcomes, and accelerating market expansion globally.
Key trends shaping the market include personalized nutrition, digital health integration, preventive care focus, and product innovation.
Rising Focus on Malnutrition Screening and Preventive Nutrition Driving the Market Demand
The market is witnessing increased regulatory focus on improving nutrition standards and preventive care. For instance, in January 2026, the U.S. FDA announced new Human Foods Program priorities aimed at reducing chronic diseases through better nutrition. This reflects a broader shift toward early identification, improved dietary quality, and enhanced clinical nutrition strategies shaping long-term market trends.
Market Breakup by Type
Market Breakup by Application
Market Breakup by Form
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Cancer Expected to Lead the Market Segment by Application
Cancer care represents a significant segment within the clinical nutrition market, accounting for over 15% of the total share during the historical period. Increasing prevalence of cancer and rising need for supportive care are driving demand for specialized immunonutrition, which helps improve patient outcomes, enhance recovery, and support treatment tolerance, contributing to the segment’s sustained growth across healthcare settings globally.
North America leads the clinical nutrition market, capturing more than 34% share during the historical period, supported by advanced healthcare infrastructure and high awareness of nutritional therapy. The region benefits from strong adoption of oral nutritional supplement solutions, particularly among aging populations and chronic disease patients, driving consistent demand and reinforcing its dominant position in the global market landscape.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott, founded in 1888 and headquartered in Abbott Park, Illinois, is a global leader in clinical nutrition with products such as Ensure and Pedialyte, addressing pediatric and adult nutrition needs. Its portfolio spans therapeutic nutrition and disease-specific formulations. Abbott continues to expand its enteral nutrition offerings to support patients across hospitals and home care settings worldwide.
Fresenius Kabi, established in 1999 and headquartered in Bad Homburg, Germany, specializes in clinical nutrition, infusion therapies, and IV drugs. Its portfolio includes parenteral and enteral nutrition products for hospitals and home care. The company focuses on innovation and patents in parenteral nutrition, expanding advanced formulations for chronic disease and critical care patients globally.
Baxter AG, founded in 1931 and headquartered in Deerfield, Illinois, provides medical products including parenteral nutrition, IV therapies, and infusion systems. Its clinical nutrition portfolio supports critically ill and hospitalized patients. Baxter focuses on delivering advanced clinical nutrition solutions through integrated systems, ensuring safe and efficient nutritional therapy across hospital and home healthcare settings worldwide.
Danone SE, founded in 1919 and headquartered in Paris, France, operates a strong medical nutrition division through Nutricia, offering specialized nutrition for infants, elderly, and disease-specific conditions. For instance, in January 2024, Danone partnered with Resilience to integrate nutrition into oncology care platforms, strengthening its global leadership in medical nutrition and personalized therapeutic solutions.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Nestlé S.A., B. Braun SE, Perrigo Company, Reckitt Benckiser Group, Ajinomoto Cambrooke, and Kate Farms.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Form |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.